Amplitude

Evommune (NYSE: EVMN) Debuts on New York Stock Exchange

Click here to view the Evommune team opening the NYSE on November 6, 2025.

Click here to read the Evommune press release on the IPO.

More news

Show all News
Portfolio news
2025.10.10 Prilenia and Ferrer to Share New Data and Analyses of Pridopidine’s Impact on Huntington’s Disease at the Huntington Study Group (HSG) Congress
Portfolio news
2025.09.22 Recognition serves as further validation of the impactful science Congruence is undertaking
Portfolio news
2025.09.09 Abdera's next-generation DLL3-targeting radiopharmaceutical therapy presented at IASLC 2025 World Conference on Lung Cancer
Portfolio news
2025.09.08 Thryv Therapeutics also presents results of SGK1 inhibition combined with Jardiance (empagliflozin), an SGLT2 inhibitor, at ESC Congress 2025